Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
2020 · New England Journal of Medicine · 2,662 citations
https://doi.org/10.1056/nejmoa2012971
M
Marina Konopleva
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2.1K
Papers
70.2K
Citations
130
h-index
738
i10-index
Marina Konopleva is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Acute Lymphoblastic Leukemia research. The author has an h-index of 130, co-authored 1776 publications.
ORCID: 0000-0002-9347-2212Papers by this author
worksVenetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
2018 · Blood · 1,826 citations
https://doi.org/10.1182/blood-2018-08-868752
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
2016 · Cancer Discovery · 1,033 citations
https://doi.org/10.1158/2159-8290.cd-16-0313
Acute myeloid leukemia: current progress and future directions
2021 · Blood Cancer Journal · 732 citations
https://doi.org/10.1038/s41408-021-00425-3
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2013 · Cancer Discovery · 717 citations
https://doi.org/10.1158/2159-8290.cd-13-0609
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
2018 · The Lancet Oncology · 692 citations
https://doi.org/10.1016/s1470-2045(18)30010-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat